Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03513562
Brief Title: Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations

First Submitted : April 19, 2018
First Submitted that Met QC Criteria : April 30, 2018
First Posted : May 1, 2018

Last Update Submitted that Met QC Criteria : March 26, 2019
Last Update Posted : March 28, 2019